Medical News

RSS

Viewpoints: Gingrich fallout; Sebelius, Matsui on Medicare reform; physicians on their rights

The Republican Presidential campaign is off to a slow start, but judging by the last week not slow enough. First Mitt Romney defends his ObamaCare prototype in Massachusetts, and now Newt Gingrich has decided to run against House Republicans on Medicare. They must be loving this at the White House.

18 May 2011

USPTO issues notice of allowance to Vermillion's Peripheral Artery Disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Panel of Biomarkers for Peripheral Artery Disease" to the company.

18 May 2011

Cytonet receives FDA orphan drug designation for liver cell infusion to treat urea cycle disorders

International biotechnology firm Cytonet, which is investigating a liver cell infusion of donated human liver cells for the treatment of urea cycle disorders in young children, announced it has been granted orphan drug designation by the U.S. Food and Drug Administration.

18 May 2011

Opinion: Innovative funding mechanisms needed for global development

"Innovation in development finance doesn't preclude innovation in other areas of development policy. In fact, they must go hand in hand," Jamie Drummond, executive director of ONE, writes in a post on the Guardian's "Poverty Matters Blog," noting findings from his group's annual report.

18 May 2011

$Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery$

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratoconus and ectasia following refractive surgery.

18 May 2011

Anxiety and depression linked to risky driving behaviour in young adolescents

Young drivers who experience anxiety and depression are more likely to take risks on the road, according to a new study by Queensland University of Technology.

18 May 2011

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

18 May 2011

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Canada

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, in Canada at St. Joseph's Healthcare - Hamilton, Ontario.

18 May 2011

Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel

ERYtech Pharma is pleased to announce it has signed an exclusive long term agreement with Teva for the registration, marketing, distribution and sale of Graspa, the company's lead product, in Israel.

18 May 2011

Nano Bridging Molecules SA receives CE marking certification for SurfLink dental product

Nano Bridging Molecules SA, A Swiss med-tech company announced that it has received CE Mark (Conformité Européenne) approval to begin marketing its SurfLink® Dental product. With its bio mimicking properties, SurfLink® Dental has been shown to allow for natural and permanent integration of dental implants for the first time. Bone seems to perceive the SurfLink® Dental product as ‘body-like’ and integrates the implant with a natural healing process, resulting in a quicker healing and a more stable integration, than without this product.

18 May 2011

Opinion: Study will unite HIV advocates, add funding pressure to Obama administration

In a post on Foreign Policy's "Passport" blog, assistant managing editor Elizabeth Dickinson looks at the potential ramifications of a recent study, which found that early antiretroviral treatment in HIV-positive people can prevent transmission by 96 percent.

18 May 2011

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

Anacor Pharmaceuticals announced today that the first patient has been dosed in a Phase 2 trial of AN2728 and AN2898 to determine safety, tolerability and efficacy of the two compounds for the topical treatment of mild-to-moderate atopic dermatitis.

18 May 2011

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer’s disease published recently by the National Institute on Aging (NIA) and the Alzheimer’s Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer’s disease at a preclinical stage, Mild Cognitive Impairment (MCI) due to Alzheimer’s disease, and dementia due to Alzheimer’s pathology.

18 May 2011

Anti-cancer drug discovery partnership formed between UMMC Cancer Institute and Natural Products Center

A new partnership to search for cancer-fighting drugs combines compound-identification and screening expertise at the University of Mississippi’s National Center for Natural Products Research with the drug development and clinical-trials capabilities at the University of Mississippi Medical Center Cancer Institute.

18 May 2011

Experts urge McDonald’s to stop marketing junk food to kids

McDonald’s has incurred the wrath of over 550 health professionals and organizations who have signed a letter to McDonald's Corp. asking the maker of Happy Meals to stop marketing junk food to kids and retire Ronald McDonald.

17 May 2011

Bill Gates urges wiser vaccine coverage worldwide to save millions

Tuesday this week, Bill Gates called for strengthened immunization programs against infectious diseases to save 4 million lives by 2015 and 10 million lives by 2020, calling it the best possible investment in global health. He was addressing the annual assembly of the World Health Organization (WHO) in Geneva, attended by health ministers from the U.N. agency's 193 member states.

17 May 2011

Fewer emergency rooms raises concern

According to a report released Tuesday this week, the number of emergency rooms has dropped by more than a quarter over the past two decades, while patient visits have kept rising. This has resulted in overcrowded ERs that can't provide optimal care for their patients, according to the new findings, published in the Journal of the American Medical Association.

17 May 2011

Decision on destroying last of the stored small pox virus samples

Health experts from all over the world are to decide this week whether to hold on to the last remaining stockpiles of smallpox, one of the deadliest diseases in history – or to proceed with their destruction.

17 May 2011

Coffee reduces prostate cancer risk

In the 20-year study of almost 50,000 men, researchers noted that those who drank at least six cups a day were 20 per cent less likely to get prostate cancer than those who never took coffee. Strikingly, they were 60 per cent less likely than the non-coffee drinkers to die of the disease. The researchers also say that decaffeinated coffee is just as effective.

17 May 2011

Excaliber subsidiary merges with VistaGen

Excaliber Enterprises, Ltd. announced today that its wholly-owned subsidiary has merged with VistaGen Therapeutics, Inc., a private biotechnology company focused on stem cell-based drug rescue and drug development. As a result of the Merger, VistaGen is a wholly-owned subsidiary of Excaliber.

17 May 2011

Medical News

Viewpoints: Gingrich fallout; Sebelius, Matsui on Medicare reform; physicians on their rights

USPTO issues notice of allowance to Vermillion's Peripheral Artery Disease biomarker patent

Cytonet receives FDA orphan drug designation for liver cell infusion to treat urea cycle disorders

Opinion: Innovative funding mechanisms needed for global development

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Anxiety and depression linked to risky driving behaviour in young adolescents

New research demonstrates how geographic profiling can help combat infectious diseases

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Canada

Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel

Nano Bridging Molecules SA receives CE marking certification for SurfLink dental product

Opinion: Study will unite HIV advocates, add funding pressure to Obama administration

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Anti-cancer drug discovery partnership formed between UMMC Cancer Institute and Natural Products Center

Experts urge McDonald’s to stop marketing junk food to kids

Bill Gates urges wiser vaccine coverage worldwide to save millions

Fewer emergency rooms raises concern

Decision on destroying last of the stored small pox virus samples

Coffee reduces prostate cancer risk

Excaliber subsidiary merges with VistaGen

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News